Lombard Odier Investment Managers has appointed Dr Bruce C Turner (pictured), MD, PhD to manage the healthcare portfolio strategy component of its flagship multi-strategy 1798 Fundamental Strategies Fund and Global Equity Long/Short Fund.
Turner brings more than 15 years of healthcare investment experience and formerly managed healthcare portfolios for First Manhattan Co. and Bank of America Merrill Lynch.
Based at LOIM’s New York subsidiary, Turner will report to Aziz Nahas, Limited Partner of Lombard Odier Investment Managers and Chief Investment Officer of the Equities business. Bruce will work closely with team analysts CJ Sylvester and Johan Utterman. Turner is replacing Jim Patricelli as the Portfolio Manager.
“Healthcare is an important sector within our multi-strategy fund and we are delighted to have Bruce’s scientific as well as financial background on board,” says Nahas. “This is a sector in which experience of managing money married with scientific insight are immensely helpful. His abilities complement the systemic and scalable investment processes we have put in place that focus on truly fluid capital allocation and preservation.”
Since completing his studies and training as a medical doctor at the University of Pennsylvania, then specialising in oncology at Yale University School of Medicine, Turner, 47, has worked as a Portfolio Manager at Diker Management, First Manhattan Co, and Bank of America Merrill Lynch where he ran a global health care fund. Since 1998 Turner has held the post of Assistant Professor in the Department of Radiation Oncology and Pathology at Thomas Jefferson University and the University of Pennsylvania School of Medicine. Turner is the author of over 20 medical publications and is considered an international authority on the treatment of breast cancer.
Geneva-headquartered LOIM, a subsidiary of Lombard Odier Darier Hentsch & Cie, managed more than CHF33.7 billion on behalf of clients at the end of September. The investment management unit offers clients a range of innovative products including single hedge fund strategies, thematic investments, convertibles funds and fundamentally weighted fixed income products.
